Novo Integrated Sciences Cost of Goods Sold 2012-2024 | NVOS

Novo Integrated Sciences cost of goods sold from 2012 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Novo Integrated Sciences Annual Cost of Goods Sold
(Millions of US $)
2024 $8
2023 $8
2022 $7
2021 $5
2020 $5
2019 $6
2018 $5
2017 $5
2016 $0
2016 $5
2015 $0
2014 $0
2013 $0
2012 $0
2012 $0
2011 $0
2011 $0
Novo Integrated Sciences Quarterly Cost of Goods Sold
(Millions of US $)
2024-08-31 $2
2024-05-31 $2
2024-02-29 $2
2023-11-30 $2
2023-08-31 $2
2023-05-31 $2
2023-02-28 $2
2022-11-30 $2
2022-08-31 $-8
2022-05-31 $11
2022-02-28 $2
2021-11-30 $2
2021-08-31 $2
2021-05-31 $1
2021-02-28 $1
2020-11-30 $1
2020-08-31 $1
2020-05-31 $1
2020-02-29 $2
2019-11-30 $2
2019-08-31 $2
2019-05-31 $2
2019-02-28 $1
2018-11-30 $1
2018-08-31 $1
2018-05-31 $1
2018-02-28 $1
2017-11-30 $1
2017-08-31 $1
2017-05-31 $1
2017-03-31
2017-02-28 $1
2016-12-31
2016-11-30 $1
2016-09-30
2016-06-30
2016-05-31 $1
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-08-31
2012-06-30
2012-03-31
2012-02-29
2011-12-31
2011-11-30
2011-09-30
2011-08-31
2011-06-30
2011-05-31
2011-03-31
2011-02-28
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.755B 19.47
Encompass Health (EHC) United States $11.734B 24.87
DaVita (DVA) United States $11.050B 14.67
Chemed (CHE) United States $8.342B 26.22
Elanco Animal Health (ELAN) United States $5.940B 12.72
Option Care Health (OPCH) United States $5.214B 23.24
RadNet (RDNT) United States $4.181B 88.48
Amedisys (AMED) United States $3.128B 21.04
LifeStance Health (LFST) United States $2.228B 0.00
Addus HomeCare (ADUS) United States $2.041B 22.41
Astrana Health (ASTH) United States $1.666B 41.26
U.S Physical Therapy (USPH) United States $1.125B 29.05
Aveanna Healthcare Holdings (AVAH) United States $1.054B 60.00
Pennant (PNTG) United States $0.985B 36.18
Atai Life Sciences (ATAI) Germany $0.278B 0.00
Daxor (DXR) United States $0.037B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
Psychemedics (PMD) United States $0.000B 0.00